Foreign direct investment in Indonesia’s manufacturing is expected to reach a record-high of USD17 billion this year, with the overall FDI already having gone up, excluding that in the area of mining. If FDI can be maintained at 2 percent of GDP, the current account deficit appears sustainable.
Foreign direct investment (FDI) rose to USD 6 billion in 3Q, well above the USD 3.8bn average of the first half of the year. Still, FDI this year is likely to come in circa USD 19 billion, 6 percent lower than in 2015 and the lowest figure since 2011, DBS reported.
While the headline figure is disconcerting, the picture is brighter under the hood. While mining has consistently attracted the greatest amount of FDI in recent years, the top destination for FDI is now machinery and electronics.
Other sectors, such as paper / printing, pharma and the auto industries have now attracted more investors compared to the mining industry. Excluding mining, FDI is likely to grow by about 5 percent this year. FDI into manufacturing is set to reach a record-high USD 17 billion, the report added.
On a net basis, FDI has risen to 2.1 percent of GDP in 3Q, well above the 1.2 percent recorded in 1H16. This broadly equals the average current account (C/A) deficit over the past two years. Back in mid-2013, Indonesia’s C/A deficit of 3.5 percent of GDP appeared unsustainable as only half of it was covered by net FDI.
Meanwhile, the USD/IDR currency pair remained highly bullish, closing at 13,563, up 0.28 percent.


Nikkei 225 Hits Record High Above 56,000 After Japan Election Boosts Market Confidence
Best Gold Stocks to Buy Now: AABB, GOLD, GDX
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
Yen Slides as Japan Election Boosts Fiscal Stimulus Expectations
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 



